Not checkedNot checked for notices yet.
De novo design of short antimicrobial lipopeptides
VANESSA POSADA, BLANCA FABIOLA ESPEJO, SERGIO ORDUZ
Anais da Academia Brasileira de Ciências · 2021
doi:10.1590/0001-3765202120210362 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Abstract The increase in bacterial resistance to antibiotics available leads to the search for new compounds with antimicrobial potential, such as peptides and lipopeptides. In this work, eight short lipopeptides with the structural pattern Cn-X1 X2 X3-NH2 were de novo designed, synthesized by Fmoc solid phase and characterized by instrumental techniques. The results of the in vitro tests indicated that two of them, LIP 4 and LIP 12 display antibacterial activity against 4 pathogenic bacteria with minimum inhibitory concentrations (MIC) between 9.50 and 100 μM and between 8.50 and 10.0 μM, respectively; they did not displayed toxicity to human erythrocytes at concentrations between 3.13 and 50.0 μM. The antibacterial mechanism of action observed by scanning electron microscopy indicate that the cell membrane was the target, causing the formation of blisters and vesicles, with size ranging from 100 to 120 nm. The lipopeptide LIP 12, with higher activity, was stable to proteases of human blood serum.
Abstract licence: CC BY
References46
- 8.
- 24.
- 29.
37 more references, whose wording the paper’s licence keeps private.
All 46 referencesReads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.